Kirchenbaum G, Pawelec G, Lehmann P
Cells. 2025; 14(3).
PMID: 39937014
PMC: 11816810.
DOI: 10.3390/cells14030223.
von La Roche D, Schumacher M, Kohn M, Trapp J, Schusser B, Rautenschlein S
Front Immunol. 2024; 15:1484288.
PMID: 39640270
PMC: 11617357.
DOI: 10.3389/fimmu.2024.1484288.
Fischer K, Lulla A, So T, Pereyra-Gerber P, Raybould M, Kohler T
Nat Biotechnol. 2024; .
PMID: 39143416
DOI: 10.1038/s41587-024-02346-5.
Lanahan S, Yang L, Jones K, Qi Z, Cruz Cabrera E, Cominsky L
Nat Immunol. 2024; 25(8):1422-1431.
PMID: 38961274
DOI: 10.1038/s41590-024-01890-1.
Kessler S, Burke B, Andrieux G, Schinkothe J, Hamberger L, Kacza J
Nat Commun. 2024; 15(1):4500.
PMID: 38802391
PMC: 11130286.
DOI: 10.1038/s41467-024-48934-6.
Recruitment of plasma cells from IL-21-dependent and IL-21-independent immune reactions to the bone marrow.
Ferreira-Gomes M, Chen Y, Durek P, Rincon-Arevalo H, Heinrich F, Bauer L
Nat Commun. 2024; 15(1):4182.
PMID: 38755157
PMC: 11099182.
DOI: 10.1038/s41467-024-48570-0.
Rapid generation of human recombinant monoclonal antibodies from antibody-secreting cells using ferrofluid-based technology.
Strazza V, Rossi M, Avati A, Tiseo G, Falcone M, Cusi M
Front Immunol. 2024; 15:1341389.
PMID: 38698845
PMC: 11064063.
DOI: 10.3389/fimmu.2024.1341389.
BCR signaling is required for posttransplant lymphoproliferative disease in immunodeficient mice receiving human B cells.
Zhang T, Cheng R, Ott A, Dahl N, Suchland E, Stoffers C
Sci Transl Med. 2024; 16(742):eadh8846.
PMID: 38598616
PMC: 11493345.
DOI: 10.1126/scitranslmed.adh8846.
Tissues of origin matter to plasma cell longevity.
Ise W, Kurosaki T
Nat Immunol. 2024; 25(2):194-195.
PMID: 38191856
DOI: 10.1038/s41590-023-01731-7.
Unraveling the diversity and functions of tissue-resident plasma cells.
Tellier J, Tarasova I, Nie J, Smillie C, Fedele P, H J Cao W
Nat Immunol. 2024; 25(2):330-342.
PMID: 38172260
DOI: 10.1038/s41590-023-01712-w.
Antigen receptor signaling and cell death resistance controls intestinal humoral response zonation.
Raso F, Liu S, Simpson M, Barton G, Mayer C, Acharya M
Immunity. 2023; 56(10):2373-2387.e8.
PMID: 37714151
PMC: 10591993.
DOI: 10.1016/j.immuni.2023.08.018.
TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells.
Asrat S, Devlin J, Vecchione A, Klotz B, Setliff I, Srivastava D
Cell Rep Methods. 2023; 3(7):100522.
PMID: 37533642
PMC: 10391570.
DOI: 10.1016/j.crmeth.2023.100522.
Intragraft B cell differentiation during the development of tolerance to kidney allografts is associated with a regulatory B cell signature revealed by single cell transcriptomics.
Guinn M, Szuter E, Yokose T, Ge J, Rosales I, Chetal K
Am J Transplant. 2023; 23(9):1319-1330.
PMID: 37295719
PMC: 11232115.
DOI: 10.1016/j.ajt.2023.05.036.
Thymus antibody-secreting cells possess an interferon gene signature and are preferentially expanded in young female mice.
Pioli K, Lau K, Pioli P
iScience. 2023; 26(3):106223.
PMID: 36890795
PMC: 9986522.
DOI: 10.1016/j.isci.2023.106223.
B cell receptor ligation induces IgE plasma cell elimination.
Wade-Vallance A, Yang Z, Libang J, Robinson M, Tarlinton D, Allen C
J Exp Med. 2023; 220(4).
PMID: 36880536
PMC: 9997509.
DOI: 10.1084/jem.20220964.
The intestine: A highly dynamic microenvironment for IgA plasma cells.
Pracht K, Wittner J, Kagerer F, Jack H, Schuh W
Front Immunol. 2023; 14:1114348.
PMID: 36875083
PMC: 9977823.
DOI: 10.3389/fimmu.2023.1114348.
Integrated Single-Cell (Phospho-)Protein and RNA Detection Uncovers Phenotypic Characteristics and Active Signal Transduction of Human Antibody-Secreting Cells.
van Buijtenen E, Janssen W, Vink P, Habraken M, Wingens L, van Elsas A
Mol Cell Proteomics. 2023; 22(2):100492.
PMID: 36623694
PMC: 9943876.
DOI: 10.1016/j.mcpro.2023.100492.
Progressive differentiation toward the long-lived plasma cell compartment in the bone marrow.
Koike T, Fujii K, Kometani K, Butler N, Funakoshi K, Yari S
J Exp Med. 2022; 220(2).
PMID: 36515679
PMC: 9754767.
DOI: 10.1084/jem.20221717.
Mass cytometry analysis reveals attrition of naïve and anergized self-reactive non-malignant B cells in chronic lymphocytic leukemia patients.
Andrieu T, Mondiere P, Jouve P, Dussurgey S, Malassigne V, Servanton H
Front Oncol. 2022; 12:1020740.
PMID: 36387187
PMC: 9661965.
DOI: 10.3389/fonc.2022.1020740.
Therapeutic Opportunities for Immunoreceptor-Engineered T Cell Therapy for Modulation of Alloimmunity.
Muralidharan K, Agarwal D, Naji A, Bhoj V
J Immunol. 2022; 209(10):1811-1816.
PMID: 36344114
PMC: 9680015.
DOI: 10.4049/jimmunol.2200542.